Low-Dose Naltrexone (LDN)

Low-Dose Naltrexone (LDN) means small amounts of an opioid-receptor blocker discussed for chronic pain, fatigue and autoimmune symptoms. People describe less aching, clearer thinking or better sleep, but also unchanged symptoms, fatigue and disturbing dreams. The dose that feels helpful and the time needed to judge it differ sharply between reports.

The same drug, a different dose discussion. Naltrexone blocks opioid receptors; it does not supply an opioid painkiller. LDN is an off-label use of much smaller oral amounts than the standard 50 mg addiction-treatment tablet, rather than a peptide, steroid or disease-specific biologic. DailyMed — Naltrexone hydrochloride tablets (Official context · Accessed 2026-09-30)

Form and release type matter to the discussion. Compounded immediate-release capsules, liquids and low-mg tablets appear in oral-use reports. Sublingual drops/troches and topical creams also appear in the discussion. Short-acting versus modified-release arguments follow the rebound theory; these forms are not established as equivalent.

The rebound story is a proposed explanation. Biohackers describe a brief receptor block followed by more endorphin activity, alongside microglia/TLR4 inflammation theory. These stories explain the interest; symptom relief does not demonstrate either mechanism. If LDN is helping with Long Covid or ME/CFS, what non pharma supplements and practices do you think might help? (Personal report · Accessed 2026-09-30)

Source context — DailyMed — Naltrexone hydrochloride tablets: Standard oral tablet labeling, not a validated low-dose symptom-duration or personal transition protocol.

Source context — If LDN is helping with Long Covid or ME/CFS, what non pharma supplements and practices do you think might help?: Very early impression; no dose or controlled comparison. OP explicitly uncertain about mechanism. Exercise/supplement substitution and long-term safety beliefs are not established by the post.

Pain and stiffness are separate from sleep. Fibromyalgia users discuss fewer aches, joint flares and headaches. shimmeringmoss reported pain/stiffness relief with insomnia; MooseBlazer slept better while stiffness and fatigue remained. One useful change need not mean every symptom improves. Reached 4 mg — I usually sleep better. That’s pretty much it. (Community discussion · Accessed 2026-09-30)

Fatigue, brain fog and crashes draw post-viral interest. An r/Biohackers author noticed early fatigue improvement after 16 months of post-COVID symptoms. Other accounts describe clearer thinking or more activity, but also worsening fatigue. More energy does not establish recovery from ME/CFS or removal of post-exertional limits. If LDN is helping with Long Covid or ME/CFS, what non pharma supplements and practices do you think might help? (Personal report · Accessed 2026-09-30) · Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30) · LDN completely pooped out (Community discussion · Accessed 2026-09-30)

Improvement, nonresponse and sleep costs coexist. Science for ME members describe modest cognitive improvement, no benefit after months, and improvement curtailed by early waking. These accounts and a self-selected poll cannot establish response rates. Experience with LDN? low dose naltrexone (Community discussion · Accessed 2026-09-30)

Sleep and mood effects can outweigh benefit. Vivid dreams, insomnia, jitteriness, irritability and excessive sleepiness appear. Headache, nausea/diarrhea, dizziness and symptom flares are also described. A flare is not evidence that healing is underway, and morning dosing does not guarantee that nightmares stop. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30) · LDN completely pooped out (Community discussion · Accessed 2026-09-30)

Source context — Reached 4 mg — I usually sleep better. That’s pretty much it.: Retrospective self-reports and changing doses; tracker sleep stages are estimates. Relative timestamps were not converted to calendar dates. Administrator’s 98% claim was not independently verified.

Source context — If LDN is helping with Long Covid or ME/CFS, what non pharma supplements and practices do you think might help?: Very early impression; no dose or controlled comparison. OP explicitly uncertain about mechanism. Exercise/supplement substitution and long-term safety beliefs are not established by the post.

Source context — Might stop LDN because of the horrible, chronic vivid nightmares: Anonymous uncontrolled accounts, changing doses and clocks, unverified formulations. Persistent post-stop nightmare claims are not causal proof; liquid mL without concentration is not mg. Advice in replies is not endorsed.

Source context — LDN completely pooped out: Uncontrolled histories. 'Endorphin boost', depleted endorphins, liquid expiry and healing-energy explanations are interpretations without biochemical/product testing.

Source context — Experience with LDN? low dose naltrexone: Self-selected forum sample; recalled exposure and changing health. Poll votes cannot establish efficacy or prevalence.

Oral: about 1–5 mg/day; 4.5 mg is a familiar reference. Community charts include 1.5, 3 and 4.5 mg once daily in successive weekly blocks. Sensitive-start discussions instead use 0.5–1 mg/day with changes about every two weeks. These are circulating approaches, not a ladder everyone needs to complete. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30)

Lower and higher reports should stay separate. One post describes 0.01→0.5 mg over months; TechPsych found 7.5 mg too jittery. Earlier discussions include 1.5–9 mg/day, benefit at 3 mg, and MCAS/split-dose totals around 8 mg or more. Higher is not automatically better. How long does LDN stay in your system? (Secondhand community claim · Accessed 2026-09-30) · Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30)

Micrograms and milligrams describe different conversations. Community ULDN-with-opioids talk ranges from roughly 1–2 mcg to 2–100 mcg/day; VLDN language often means 100–500 mcg. Neither is interchangeable with milligram LDN. Split-dose reports need a daily total, not only an amount per administration.

Bedtime, morning and evening all appear. The traditional chart says 30–60 minutes before bed. Morning switches for dreams/insomnia, a 6 p.m. account, empty-stomach customs and one-hour thyroid-medication spacing also occur. They do not establish an optimal clock, mandatory food rule or reliable interaction workaround. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30)

Morning dosing helped one person and failed another. kwil2 described relief from nightmares after moving to morning, later tolerating 4.5 mg at night and reporting more activity. powdertojinx had distressing nightmares for a month at 1 mg in the morning and ultimately stopped after several more weeks. These accounts contradict a universal morning fix. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30)

Source context — Might stop LDN because of the horrible, chronic vivid nightmares: Anonymous uncontrolled accounts, changing doses and clocks, unverified formulations. Persistent post-stop nightmare claims are not causal proof; liquid mL without concentration is not mg. Advice in replies is not endorsed.

Source context — How long does LDN stay in your system?: Label numbers repeated by a community account, not new LDN measurements. Linked chart not inspected. Hold/restart advice is not a clinical clearance rule.

Early sensations can precede useful benefit. Reports include first-day clarity at 1.5 mg, immediate nightmares, and sleepiness about an hour after a 1.5 mg/day dose. Those sensations are different endpoints; none supplies a reliable time-to-pain-relief. Reached 4 mg — I usually sleep better. That’s pretty much it. (Community discussion · Accessed 2026-09-30) · Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30) · LDN completely pooped out (Community discussion · Accessed 2026-09-30)

Weeks to months, with no guaranteed response. One sleep account improved around six weeks at 1.5 mg. Earlier discussion uses 8–12-week stable-dose or 2–3-month checkpoints. Dose changes complicate the clock; some report no benefit after months. Reached 4 mg — I usually sleep better. That’s pretty much it. (Community discussion · Accessed 2026-09-30) · Experience with LDN? low dose naltrexone (Community discussion · Accessed 2026-09-30)

No dependable single-dose benefit window. The circulated 8–18+ hour endorphin/immune-effect claim is unmeasured lore. TechPsych described activation after a 6 p.m. dose and relaxation by 11 p.m. That personal clock cannot establish analgesia or clearance. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30)

Effects can persist, adapt or fade during continued use. One author’s energy and pain improvement disappeared after two weeks. MooseBlazer still described sleep benefit at seven months, with occasional insomnia, then normal sleep at the year mark. Reports do not establish how long benefit persists after stopping. LDN completely pooped out (Community discussion · Accessed 2026-09-30) · Reached 4 mg — I usually sleep better. That’s pretty much it. (Community discussion · Accessed 2026-09-30)

Four hours for naltrexone; 13 hours for its metabolite. Reddit repeats these standard-label human figures. A Health Rising commenter instead gives 15 hours for the metabolite. These circulated numbers are not community LDN measurements; the label gives 13 hours. How long does LDN stay in your system? (Secondhand community claim · Accessed 2026-09-30) · The Strangeness of Low Dose Naltrexone — reader comments (Community discussion · Accessed 2026-09-30)

Receptor-block and benefit clocks are not half-life. Community lore describes several hours of blockade followed by downstream effects. Neither those narratives nor the opened posts establish an exact LDN elimination curve, a safe opioid-restart clock, or how long pain relief will feel noticeable. How long does LDN stay in your system? (Secondhand community claim · Accessed 2026-09-30)

Standard-dose pharmacology stays separate. DailyMed gives parent/metabolite half-lives of 4/13 hours, peaks within one hour, and oral bioavailability of 5–40%; dose proportionality was studied over 50–200 mg. Its opioid-free interval is 7–10 days for prior short-acting opioid dependence, with longer vulnerability after methadone/buprenorphine. These are label contexts, not an LDN timing recipe. DailyMed — Naltrexone hydrochloride tablets (Official context · Accessed 2026-09-30)

Source context — Reached 4 mg — I usually sleep better. That’s pretty much it.: Retrospective self-reports and changing doses; tracker sleep stages are estimates. Relative timestamps were not converted to calendar dates. Administrator’s 98% claim was not independently verified.

Source context — Might stop LDN because of the horrible, chronic vivid nightmares: Anonymous uncontrolled accounts, changing doses and clocks, unverified formulations. Persistent post-stop nightmare claims are not causal proof; liquid mL without concentration is not mg. Advice in replies is not endorsed.

Source context — LDN completely pooped out: Uncontrolled histories. 'Endorphin boost', depleted endorphins, liquid expiry and healing-energy explanations are interpretations without biochemical/product testing.

Source context — Experience with LDN? low dose naltrexone: Self-selected forum sample; recalled exposure and changing health. Poll votes cannot establish efficacy or prevalence.

Source context — How long does LDN stay in your system?: Label numbers repeated by a community account, not new LDN measurements. Linked chart not inspected. Hold/restart advice is not a clinical clearance rule.

Source context — The Strangeness of Low Dose Naltrexone — reader comments: Unverified reader histories/interpretations. Article is advocacy-oriented and includes named clinic/case summaries; those are not independent community experiments. No dose/benefit consensus inferred.

Source context — DailyMed — Naltrexone hydrochloride tablets: Standard oral tablet labeling, not a validated low-dose symptom-duration or personal transition protocol.

Pain/autoimmune talk usually describes ongoing daily use. Months-to-years use and stable divided doses appear rather than short peptide-style cycles. Travel pauses and symptom reassessments are reported; no required holiday schedule emerges. Reached 4 mg — I usually sleep better. That’s pretty much it. (Community discussion · Accessed 2026-09-30)

A break does not reliably restore response. TechPsych takes Sundays off on an unverified sensitivity theory. Adorable_Pen_76 tried two separate week-long breaks after benefit faded, without restoring it. Restarting and changing doses are personal histories, not proof of receptor reset. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30) · LDN completely pooped out (Community discussion · Accessed 2026-09-30)

Five days on, two off belongs to cancer-adjacent lore. Trust/clinic discussions attach this pattern to a 4.5 mg goal. It is not a general pain cycle or established oncology treatment. Opioid transitions and surgery holds are clinical interaction planning, not recreational cycling.

Source context — Reached 4 mg — I usually sleep better. That’s pretty much it.: Retrospective self-reports and changing doses; tracker sleep stages are estimates. Relative timestamps were not converted to calendar dates. Administrator’s 98% claim was not independently verified.

Source context — Might stop LDN because of the horrible, chronic vivid nightmares: Anonymous uncontrolled accounts, changing doses and clocks, unverified formulations. Persistent post-stop nightmare claims are not causal proof; liquid mL without concentration is not mg. Advice in replies is not endorsed.

Source context — LDN completely pooped out: Uncontrolled histories. 'Endorphin boost', depleted endorphins, liquid expiry and healing-energy explanations are interpretations without biochemical/product testing.

Other treatments complicate credit. Earlier reports combine LDN with thyroid replacement, pain medicines, PT/sleep work, diet and IBD therapies. Vitamin D, omega-3s, selenium/zinc and glutathione appear in autoimmune lists; BPC-157, KPV, Thymosin Alpha-1, LL-37, metformin and cannabinoids are occasional co-mentions. No established synergy or fixed blend ratio follows.

Opioid medicines need clinical coordination. Naltrexone can block analgesia and precipitate severe withdrawal, including with tramadol. Surgery or emergency pain treatment needs a prescriber’s plan; neither low-dose wording nor a forum washout number makes a combination safe. DailyMed — Naltrexone hydrochloride tablets (Official context · Accessed 2026-09-30)

Micrograms and milligrams describe different conversations. Community ULDN-with-opioids talk ranges from roughly 1–2 mcg to 2–100 mcg/day; VLDN language often means 100–500 mcg. Neither is interchangeable with milligram LDN. Split-dose reports need a daily total, not only an amount per administration.

Source context — DailyMed — Naltrexone hydrochloride tablets: Standard oral tablet labeling, not a validated low-dose symptom-duration or personal transition protocol.

Opioid medicines need clinical coordination. Naltrexone can block analgesia and precipitate severe withdrawal, including with tramadol. Surgery or emergency pain treatment needs a prescriber’s plan; neither low-dose wording nor a forum washout number makes a combination safe. DailyMed — Naltrexone hydrochloride tablets (Official context · Accessed 2026-09-30)

Sleep and mood effects can outweigh benefit. Vivid dreams, insomnia, jitteriness, irritability and excessive sleepiness appear. Headache, nausea/diarrhea, dizziness and symptom flares are also described. A flare is not evidence that healing is underway, and morning dosing does not guarantee that nightmares stop. Might stop LDN because of the horrible, chronic vivid nightmares (Community discussion · Accessed 2026-09-30) · LDN completely pooped out (Community discussion · Accessed 2026-09-30)

Formulation changes add uncertainty. Fillers, calcium-carbonate debate, release type and liquid-versus-capsule changes occur in community troubleshooting. Splitting a 50 mg tablet or dividing capsule powder by eye does not establish accurate low-mg amounts. A changed refill is not proof of a bad batch. LDN completely pooped out (Community discussion · Accessed 2026-09-30)

Positive stories do not settle fibromyalgia efficacy. The FINAL trial’s 99 women received 6 mg/day or placebo for 12 weeks; LDN did not demonstrate superior pain relief. Earlier small positive studies and uncontrolled clinic response percentages do not establish an individual success probability or effectiveness across autoimmune conditions. FINAL trial — Naltrexone 6 mg once daily versus placebo in women with fibromyalgia (Official context · Accessed 2026-09-30)

The autoimmune label covers different hopes. Hashimoto’s, Crohn’s/IBD, MS, CRPS and MCAS discussions seek fewer flares, less pain or better daily functioning. Thyroid-antibody, immune-reset and cancer claims go beyond those experiences; symptom reports do not establish disease modification or replace condition-specific treatment.

Source context — DailyMed — Naltrexone hydrochloride tablets: Standard oral tablet labeling, not a validated low-dose symptom-duration or personal transition protocol.

Source context — Might stop LDN because of the horrible, chronic vivid nightmares: Anonymous uncontrolled accounts, changing doses and clocks, unverified formulations. Persistent post-stop nightmare claims are not causal proof; liquid mL without concentration is not mg. Advice in replies is not endorsed.

Source context — LDN completely pooped out: Uncontrolled histories. 'Endorphin boost', depleted endorphins, liquid expiry and healing-energy explanations are interpretations without biochemical/product testing.

Source context — FINAL trial — Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: Author-hosted abstract, not full-text review. Specific population/endpoint; not a verdict on every community use.